Home > Insider Trading > Filing (0001131096-16-000292)

Filing Details

Accession Number:: 0001131096-16-000292
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-03 19:55:20
Reporting Period:: 2016-03-01

Filing Date:: 2016-03-03
Accepted Time:: 2016-03-03 19:55:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131096	Athenahealth Inc	ATHN	Services-Business Services, Nec (7389)	043387530

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1496188	Ed Park	C/O Athenahealth, Inc. 311 Arsenal Street Watertown MA 02472	Evp And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2016-03-01	1,163	$131.43	26,270	No	4	S	Direct
Common Stock	Disposition	2016-03-01	337	$132.44	25,933	No	4	S	Direct
Common Stock	Acquisiton	2016-03-01	1,906	$0.00	27,839	No	4	M	Direct
Common Stock	Disposition	2016-03-01	897	$132.37	26,942	No	4	F	Direct
Common Stock	Acquisiton	2016-03-01	3,366	$0.00	30,308	No	4	M	Direct
Common Stock	Disposition	2016-03-01	1,585	$132.37	28,723	No	4	F	Direct
Common Stock	Disposition	2016-03-01	2,843	$132.37	25,880	No	4	F	Direct
Common Stock	Disposition	2016-03-01	1,661	$132.37	24,219	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Unit	Disposition	2016-03-01	1,906	$0.00	1,906	$0.00
Common Stock	Performance Stock Unit	Disposition	2016-03-01	3,366	$0.00	3,366	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,812		2018-03-01	No	4	M	Direct
10,099		2019-03-01	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 30, 2015, in accordance with Rule 10b5-1.
This price represents the weighted average of sales ranging from $131.15 to $131.85. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average of sales ranging from $132.22 to $132.82. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.
Shares withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under theSecurities Exchange Act of 1934.
These shares were withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the Reporting Person on March 1, 2012. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
These shares were withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the Reporting Person on March 1, 2013. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
On March 3, 2014, the Reporting Person was awarded 7,623 performance stock units (PSUs). The PSUs vest in four equal annual installments beginning on March 1, 2015 based on the Issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2014. On February 10, 2015, the Compensation Committee of the Board of Directors of the Issuer certified that the performance criteria for 2014 was met, resulting in vesting of the PSUs as to 1,906 shares on March 1, 2016.
On March 2, 2015, the Reporting Person was awarded 13,465 PSUs. The PSUs vest in four equal annual installments beginning on March 1, 2016 based on the Issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2015. On February 9, 2016, the Compensation Committee of the Board of Directors of the Issuer certified that the performance criteria for 2015 was met, resulting in vesting of the PSUs as to 3,366 shares on March 1, 2016.